Natural product drug discovery in the artificial intelligence era

FI Saldívar-González, VD Aldas-Bulos… - Chemical …, 2022 - pubs.rsc.org
Natural products (NPs) are primarily recognized as privileged structures to interact with
protein drug targets. Their unique characteristics and structural diversity continue to marvel …

Structure-based virtual screening for ligands of G protein–coupled receptors: what can molecular docking do for you?

F Ballante, AJ Kooistra, S Kampen, C de Graaf… - Pharmacological …, 2021 - Elsevier
G protein–coupled receptors (GPCRs) constitute the largest family of membrane proteins in
the human genome and are important therapeutic targets. During the last decade, the …

Modeling the expansion of virtual screening libraries

J Lyu, JJ Irwin, BK Shoichet - Nature chemical biology, 2023 - nature.com
Recently,'tangible'virtual libraries have made billions of molecules readily available.
Prioritizing these molecules for synthesis and testing demands computational approaches …

Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity

A Rayan, J Raiyn, M Falah - PloS one, 2017 - journals.plos.org
Cancer is considered one of the primary diseases that cause morbidity and mortality in
millions of people worldwide and due to its prevalence, there is undoubtedly an unmet need …

The application of in silico drug-likeness predictions in pharmaceutical research

S Tian, J Wang, Y Li, D Li, L Xu, T Hou - Advanced drug delivery reviews, 2015 - Elsevier
The concept of drug-likeness, established from the analyses of the physiochemical
properties or/and structural features of existing small organic drugs or/and drug candidates …

Virtual screening strategies in drug discovery: a critical review

A Lavecchia, C Di Giovanni - Current medicinal chemistry, 2013 - ingentaconnect.com
Virtual screening (VS) is a powerful technique for identifying hit molecules as starting points
for medicinal chemistry. The number of methods and softwares which use the ligand and …

Challenges of antibacterial discovery

LL Silver - Clinical microbiology reviews, 2011 - Am Soc Microbiol
The discovery of novel small-molecule antibacterial drugs has been stalled for many years.
The purpose of this review is to underscore and illustrate those scientific problems unique to …

Impact of high-throughput screening in biomedical research

R Macarron, MN Banks, D Bojanic, DJ Burns… - Nature reviews Drug …, 2011 - nature.com
High-throughput screening (HTS) has been postulated in several quarters to be a
contributory factor to the decline in productivity in the pharmaceutical industry. Moreover, it …

Nonantimicrobial actions of macrolides: overview and perspectives for future development

JA Kricker, CP Page, FR Gardarsson… - Pharmacological …, 2021 - Elsevier
Macrolides are among the most widely prescribed broad spectrum antibacterials, particularly
for respiratory infections. It is now recognized that these drugs, in particular azithromycin …

Lead-and drug-like compounds: the rule-of-five revolution

CA Lipinski - Drug discovery today: Technologies, 2004 - Elsevier
Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end
2004. Trends in the RO5 literature explosion that can be discerned are the further definitions …